| | Interval between infections (yrs) |
---|
Clinical categorya | All data (n = 502) | Cohort extended datasetc(n = 195) |
---|
Infection one | Infection two | N | Mean | Min | Max | N | Mean | Min | Max |
Any | Any | 502 | 3.45 | 0.18 | 12.57 | 195 | 1.85 | .27 | 4.96 |
Subclinicalb | Subclinicalb | 45 | 1.74 | 0.78 | 3.25 | 45 | 1.74 | 0.78 | 3.25 |
Subclinicalb | Symptomatic | 26 | 3.03 | 0.65 | 12.26 | 21 | 1.84 | 0.65 | 4.22 |
Symptomatic | Subclinicalb | 23 | 2.15 | 0.77 | 4.96 | 23 | 2.15 | 0.77 | 4.96 |
Symptomatic | Symptomatic | 323 | 4.27 | 0.18 | 12.57 | 21 | 2.35 | 0.27 | 4.28 |
- aClinical category at infection one and two.
- bSubclinical infections were only captured from cohort studies. Symptomatic infections include all symptomatic infections from Bangkok and Kamphaeng Phet. 56 infection one’s and 42 infection two’s were unable to be clinically categorized as symptomatic or subclinical due to occurrence out of the active study surveillance period and not seeking hospital care (listed as ‘Any’ in the table).
- cOnly infections in cohort subjects were included in this subgroup; includes infections detected from non-study hospital-basedpassive surveillance within five years after infection one.